F053 The Diverse Spectrum of Photodermatoses: When to Suspect and What to Do
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
Although sunlight sustains human life, it also has the direct capacity to induce a diverse range of harmful effects on the skin including dyspigmentation, inflammation, and neoplasia. Photosensitivity is a broad concept that is often overlooked and needs to be better understood in terms of specific reaction patterns and pathophysiologic processes. This session is aimed at equipping participants with practical knowledge about when to suspect a light-induced skin problem and what to specifically do about it.
LEARNING OBJECTIVES
Recognize the broad diversity, range, and features of skin conditions caused by light.
Describe a practical approach to recognizing and diagnosing a patient with light-induced skin disease.
Utilize the most current evidence-based approach to managing abnormal light sensitivity.
SCHEDULE
8:30 PM
The When, Why, and How of Photosensitivity
Harvey Lui, MD, FAAD
8:40 PM
Drug Photosensitivity
Tashmeeta Ahad, MD
8:58 PM
Idiopathic Photodermatoses
Sunil Kalia, MD
9:16 PM
Photosensitivity with Connective Tissue Disease
Benjamin F. Chong, MD, MSc, FAAD
9:34 PM
Discussion/Q&A
9:39 PM
Porphyrias and Metabolic Photosensitivity
Robert P. Sarkany, MD, MBBS
9:57 PM
Photodermatoses in Skin of Color
Tasneem Mohammad, MD, FAAD
10:15 PM
An Approach to Photodermatoses and Office-based Phototesting
Harvey Lui, MD, FAAD
10:25 PM
Discussion/Q&A
SPEAKERS
Tashmeeta Ahad, MD
Benjamin F. Chong, MD, MSc, FAAD
Sunil Kalia, MD
Harvey Lui, MD, FAAD
Tasneem Mohammad, MD, FAAD
Robert P. Sarkany, MD, MBBS
HANDOUTS
SPEAKER DISCLOSURES
Tashmeeta Ahad, MD
Beiersdorf – Advisory Board(Honoraria); CeraVe – Investigator(Grants/Research Funding); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding); L'Oreal – Advisory Board(Honoraria); Leo Pharma – Advisory Board(Honoraria), Consultant (1099 relationship)(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Sanofi – Advisory Board(Honoraria);
Benjamin F. Chong, MD, MSc, FAAD
Amgen – Other(Honoraria); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cesas Medical Limited – Speaker(Honoraria); EMD Serono – Consultant(Honoraria), Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Consultant(Honoraria); Lupus Research Alliance – Consultant (1099 relationship)(Honoraria); MAPI Research Trust – Other(Patent royalties or other compensation for Intellectual Property Rights); Pfizer Inc. – Investigator(Grants/Research Funding);
Sunil Kalia, MD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Bausch Health – Advisory Board(Honoraria); Eli Lilly and Company – Advisory Board(Honoraria); Janssen Pharmaceuticals, Inc – Consultant(Honoraria); Leo Pharma Inc – Other(Grants/Research Funding); Leo Pharma Inc. – Consultant(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); UBC Dermatology – Board of Directors(Other Financial Benefit);
Harvey Lui, MD, FAAD
AbbVie – Consultant(Fees); Celltrion – Advisory Board(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Consultant(Fees), Investigator(Grants/Research Funding); L'Oreal – Speaker(Honoraria); Lumen Health Innovations Inc. – Founder(Stock); Pfizer Inc. – Investigator(Grants/Research Funding); RepliCel Life Sciences – Stockholder(Stock); Vita Imaging – Consultant(Fees);
Tasneem Mohammad, MD, FAAD
Apogee Therapeutics – Consultant (1099 relationship)(Honoraria); atheneum – Consultant(Honoraria); Avita – Consultant (1099 relationship)(Fees), Investigator(Grants/Research Funding); Beiersdorf – Consultant (1099 relationship)(Fees); Beiersdorf, Inc. – Speaker(Honoraria); Clinuvel – Investigator(Grants/Research Funding); Disc Medicine – Investigator(Grants/Research Funding); Guidepoint Global, LLC – Consultant(Honoraria); Immune Tolerance Network – Investigator(Grants/Research Funding); Incyte Corporation – Investigator(Grants/Research Funding); Kenvue – Consultant (1099 relationship)(Honoraria); Medscape – Speaker/Faculty Education(Honoraria); Mitsubishi Tanabe Pharma Corporation – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); polaris health – Speaker/Faculty Education(Honoraria); Third Bridge – Consultant (1099 relationship)(Honoraria);
Robert P. Sarkany, MD, MBBS
No financial relationships exist with ineligible companies.